This filing is an Initial Statement of Beneficial Ownership (Form 3) for Baird Medical Investment Holdings Ltd (BDMD). The reporting owner is ExcelFin SPAC LLC, which holds 4,249,031 ordinary shares directly. This ownership is further detailed through its managing members, Grand Fortune Capital, LLC (GFC) and ExcelFin ...

This filing is an initial statement of beneficial ownership of securities (Form 3) for BioNexus Gene Lab Corp (BGLC). The reporting owner is Chong Set Fui, identified by CIK 0002076847. Fui Chong Set, the CFO of the company, has a direct ownership of the reported securities. The filing indicates that following the tran...

This filing reports the initial beneficial ownership of securities for Low Jook Yuen, a director at BioNexus Gene Lab Corp (BGLC). The filing indicates that following a transaction, Mr. Low Jook Yuen directly owns 1261 shares of the company's common stock. The report was filed on July 31, 2026, with the period of repor...

This filing reports that Yap Chee Keong, a director at BioNexus Gene Lab Corp, has initially acquired 0 shares of common stock. The ownership is direct, and the report was filed on March 7, 2022....

This filing reports the initial statement of beneficial ownership of securities for Tan Lee Su-Leng, CEO and Director of BioNexus Gene Lab Corp. The report, filed on August 15, 2023, indicates no securities owned following the transaction. The owner resides in Kuala Lumpur, Malaysia....

This filing is an initial statement of beneficial ownership of securities (Form 3) for BioNexus Gene Lab Corp (BGLC). The reporting owner is Chong Set Fui, identified by CIK 0002076847. Fui Chong Set, the CFO of the company, has a direct ownership of the reported securities. The filing indicates that following the tran...

This filing is an initial report of beneficial ownership on Form 3 for Patricia G. Gauthier, a director at Decoy Therapeutics Inc. The filing indicates that no securities are beneficially owned by Ms. Gauthier as of the reporting date. The document also includes an exhibit which is a Power of Attorney. This Power of At...

This filing is an Initial Statement of Beneficial Ownership (Form 3) for Baird Medical Investment Holdings Ltd (BDMD). The reporting owner is ExcelFin SPAC LLC, which holds 4,249,031 ordinary shares directly. This ownership is further detailed through its managing members, Grand Fortune Capital, LLC (GFC) and ExcelFin ...

This filing details a Form 3, Initial Statement of Beneficial Ownership, for GREENLIGHT CAPITAL RE, LTD. (GLRE). The reporting owner, Ariel Warszawski, who is a director at the company, reported 0 shares owned following the transaction. The ownership is direct. The filing date was July 31, 2026, with the period of repo...

This filing is an initial report of beneficial ownership on Form 3 for Patricia G. Gauthier, a director at Decoy Therapeutics Inc. The filing indicates that no securities are beneficially owned by Ms. Gauthier as of the reporting date. The document also includes an exhibit which is a Power of Attorney. This Power of At...

This filing is an Exhibit 24, a Power of Attorney, for Travis Witteveen, Head of Products and Portfolio at Gen Digital Inc. The document, dated June 15, 2026, authorizes Bryan Ko, Whitney Clark, and Kathryn White to act as attorneys-in-fact. They are empowered to execute, deliver, and file Forms 3, 4, and 5, including ...

This filing reports the initial beneficial ownership of securities for Low Jook Yuen, a director at BioNexus Gene Lab Corp (BGLC). The filing indicates that following a transaction, Mr. Low Jook Yuen directly owns 1261 shares of the company's common stock. The report was filed on July 31, 2026, with the period of repor...

This filing reports the initial beneficial ownership of securities by Brendan P. O'Grady, Chief Executive Officer and Director of Nasus Pharma Ltd. (NSRX). The report is dated July 31, 2026, and pertains to the period ending July 27, 2026. Mr. O'Grady, residing in Tel-Aviv-Yafo, Israel, holds no securities directly as ...

This filing reports the initial beneficial ownership of securities by Brendan P. O'Grady, Chief Executive Officer and Director of Nasus Pharma Ltd. (NSRX). The report is dated July 31, 2026, and pertains to the period ending July 27, 2026. Mr. O'Grady, residing in Tel-Aviv-Yafo, Israel, holds no securities directly as ...

This filing details a Limited Power of Attorney granted by Gregory Hyde Williams, a director at Paymentus Holdings, Inc. (PAY), to Thomas C. Barnds. This appointment authorizes Barnds to act on Williams' behalf regarding securities transactions and filings with the SEC. This includes executing necessary forms such as S...

This filing details insider ownership for TOP Financial Group Ltd. Yang Junli, identified as a 10% owner, officer, and director, reports holdings through two entities: Zhong Yang Holdings (BVI) Limited and QUANTUM LEAP LIMITED. Yang Junli holds 10,000,000 Class B Ordinary Shares directly. Indirectly, through Zhong Yang...

This filing reports insider ownership information for TOP Financial Group Ltd. The reporting owner, Yuen Ka Fai, who is a Director & CEO of the company, has reported no securities owned as of March 18, 2026. The signature date was July 31, 2026. This is a Form 3 filing, which is an initial statement of beneficial owner...

This filing reports the initial statement of beneficial ownership of securities for Tan Lee Su-Leng, CEO and Director of BioNexus Gene Lab Corp. The report, filed on August 15, 2023, indicates no securities owned following the transaction. The owner resides in Kuala Lumpur, Malaysia....

This filing details a Power of Attorney granted by Douglas J. Williamson, a director of Vistagen Therapeutics, Inc., to Nick B. Tressler and Shawn K. Singh. The attorneys-in-fact are authorized to act on Mr. Williamson's behalf regarding SEC filings, including preparing, executing, and submitting forms such as 3, 4, 5,...

This filing details a Form 3, Initial Statement of Beneficial Ownership, for GREENLIGHT CAPITAL RE, LTD. (GLRE). The reporting owner, Ariel Warszawski, who is a director at the company, reported 0 shares owned following the transaction. The ownership is direct. The filing date was July 31, 2026, with the period of repo...

This filing details a Limited Power of Attorney granted by Gregory Hyde Williams, a director at Paymentus Holdings, Inc. (PAY), to Thomas C. Barnds. This appointment authorizes Barnds to act on Williams' behalf regarding securities transactions and filings with the SEC. This includes executing necessary forms such as S...

This filing details a Power of Attorney granted by Douglas J. Williamson, a director of Vistagen Therapeutics, Inc., to Nick B. Tressler and Shawn K. Singh. The attorneys-in-fact are authorized to act on Mr. Williamson's behalf regarding SEC filings, including preparing, executing, and submitting forms such as 3, 4, 5,...

This filing is an Exhibit 24, a Power of Attorney, for Travis Witteveen, Head of Products and Portfolio at Gen Digital Inc. The document, dated June 15, 2026, authorizes Bryan Ko, Whitney Clark, and Kathryn White to act as attorneys-in-fact. They are empowered to execute, deliver, and file Forms 3, 4, and 5, including ...

This filing details insider ownership for TOP Financial Group Ltd. Yang Junli, identified as a 10% owner, officer, and director, reports holdings through two entities: Zhong Yang Holdings (BVI) Limited and QUANTUM LEAP LIMITED. Yang Junli holds 10,000,000 Class B Ordinary Shares directly. Indirectly, through Zhong Yang...

This filing reports that Yap Chee Keong, a director at BioNexus Gene Lab Corp, has initially acquired 0 shares of common stock. The ownership is direct, and the report was filed on March 7, 2022....